Policy Conference Documents and Joint Task Force Statements

Position statements - 2012

• Thoracic Endovascular Aortic Repair (TEVAR) for the treatment of aortic diseases a position statement from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). M Grabenwoeger, F Alfonso, J Bachet, R Bonser, M Czerny, H Eggebercht, A Evangelista, R Fattori, H Jakob, L Loenn, C A Nienaber, G Rocchi, H Rousseau, M Thompson, E Weigang and R Erbel. Eur Heart J - doi:10.1093/eurheartj/ehs074  - 2012        

Policy Conference Documents

• Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. 
  JP Bassand FESC, N Danchin FESC, G Filippatos FESC, A Gitt FESC, C Hamm FESC, S Silber FESC, M Tubaro FESC, F Weidinger FESC. Eur Heart J 2005;26:2733-41
• The Need for Resources for Clinical Reseach.
  Proceedings of a Policy Conference held at the European Heart House, 27-28 June 2002: Executive Summary
  JB Bassand FESC, J Martin FESC, L Rydén FESC, M Simoons FESC
  Eur Heart J 2003;24:1171-73 
  The Need for Resources for Clinical Reseach: the European Society of Cardiology calls for European, international collaboration
  JB Bassand FESC, J Martin FESC, L Rydén FESC, M Simoons FESC
  Lancet 2002;360:1866-69
• ESC-ERC Policy Conference on Use of AEDs 
  ESC-ERC recommendations for the use of automated external defibrillators (AEDS) in Europe. SG Priori FESC, LL Bossaert FESC, DA Chamberlain FESC, C Napolitano FESC, HR Arntz, RW Koster, KG Monsieurs, A Capucci FESC, HJ Wellens FESC
  Eur Heart J 2004;25:437-445
  • Supplement 1
  • Supplement 2
  • Supplement 3 
• The Potential for QT Prolongation and Proarrhythmia by Non-antiarrhythmic Drugs. Clinical and Regulatory Implications. 
  Report on a Policy Conference of the ESC.
  Eur Heart J 2000;21
• Re-Use of Devices in Cardiology. 
  Proceedings of a Policy Conference at the European Heart House, February 5-6, 1998
  Prof. Lars Rydén FESC, President of the European Society of Cardiology
  Eur Heart J 1998;19:1628-131

Task Force Statements

• Legal implications of Medical Guidelines -PJ Schwartz FESC, G Breithardt FESC, Howard, DG Julian EFESC, N Reherqvist- Ahlberg - EHJ 1999;20:1552-1157 
• Driving and Heart Disease - MC Petch EFESC - EHJ 1998;19:1165-1172
• Pre-Hospital Management of Acute Heart Attacks -H Arntz, L Bossaert FESC, P Carli, D Chamberlain EFESC, M Davies, M Dellborg, W Dick, T Haghfelt FESC, S Hapnes, R Juchems, H Loewel, R Koster, A Leizorovicz, M Marzilli FESC, J Rawles, C Robertson, M Ruano - EHJ 1998;19:1140-1164
• Clinical Role of Magnetic Resonance in Cardiovascular Disease -S Neubauer, D Revel, A de Roos, AC van Rossum FESC, G von Schulthess, U Sechtem FESC, L Sieverding, SR Underwood FESC, E van der Wall FESC - EHJ 1998;19:19-39
• Burden of Burden of Cardiovascular Diseases Diseases Mortality in Europe - S Sans, H Kesteloot EFESC, D Kromhout on behalf of the Task Force - EHJ 1997;18:1231-1248
• Heart Rate Variability: Standards of Measurement, Physiological Interpretation and Clinical Use -AJ Camm FESC, M Malik FESC (Chairpersons) EHJ 1996;17:354-381
• Clinical Investigation of anti-arrhythmic devices
  A statement for healthcare professionals from a joint task force of the North American Society of Pacing and Electrophysiology (NASPE), the American College of Cardiology (ACC), the American Heart Association (AHA), and the former Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology (ESC)
  Eur Heart J 1995;16:446-59
  PACE - Pacing and Electrophysiology 1995;18:637-654
  JACC 1995;2:961 - 973 Circulation 1995;91:2097-2109